SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphoma
Abstract Background Research on the fatty acid metabolism related gene SLC27A2 is currently mainly focused on solid tumors, and its mechanism of action in hematological tumors has not been reported. Method This study aims to explore the pathological and immune mechanisms of the fatty acid metabolism...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2024-04-01
|
| Colección: | BMC Medical Genomics |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s12920-024-01853-3 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
